Patents by Inventor Brian Warrington

Brian Warrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR TREATING ACNE AND DERMATOLOGICAL CONDITIONS
    Publication number: 20240130980
    Abstract: The present disclosure generally relates to compositions comprising unique combinations of cannabinoids, antioxidants, and cofactors. The present disclosure also provides methods of making the compositions and methods for using the compositions for the treatment of mitochondrial ATP deficit disorders.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 25, 2024
    Inventors: Brian WARRINGTON, Karyn GROSSMAN, Oludare ODUMOSU, Zoltan KEREKES
  • Compositions for treating acne and dermatological conditions
    Patent number: 11890260
    Abstract: The present disclosure generally relates to compositions comprising unique combinations of cannabinoids, antioxidants, and cofactors. The present disclosure also provides methods of making the compositions and methods for using the compositions for the treatment of mitochondrial ATP deficit disorders.
    Type: Grant
    Filed: July 26, 2021
    Date of Patent: February 6, 2024
    Assignee: Ilera Derm LLC
    Inventors: Brian Warrington, Karyn Grossman, Oludare Odumosu, Zoltan Kerekes
  • COMPOSITIONS FOR TREATING ACNE AND DERMATOLOGICAL CONDITIONS
    Publication number: 20210361591
    Abstract: The present disclosure generally relates to compositions comprising unique combinations of cannabinoids, antioxidants, and cofactors. The present disclosure also provides methods of making the compositions and methods for using the compositions for the treatment of mitochondrial ATP deficit disorders.
    Type: Application
    Filed: July 26, 2021
    Publication date: November 25, 2021
    Inventors: Brian WARRINGTON, Karyn GROSSMAN, Oludare ODUMOSU, Zoltan KEREKES
  • Phenylephrine formulations with improved stability
    Patent number: 10130627
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: November 20, 2018
    Assignee: GlaxoSmithKine Consumer Healthcare S.A.
    Inventors: Timothy Dungan, Brian Warrington
  • PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY
    Publication number: 20160015815
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Application
    Filed: May 29, 2015
    Publication date: January 21, 2016
    Applicant: Novartis AG
    Inventors: Timothy DUNGAN, Brian WARRINGTON
  • Phenylephrine Formulations With Improved Stability
    Publication number: 20150265713
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Application
    Filed: June 3, 2015
    Publication date: September 24, 2015
    Inventors: Timothy DUNGAN, Brian WARRINGTON
  • PHEHYLEPHRINE FORMULATIONS WITH IMPROVEDS STABILITY
    Publication number: 20110237616
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Application
    Filed: December 11, 2009
    Publication date: September 29, 2011
    Applicant: Novartis AG
    Inventors: Timothy Dungan, Brian Warrington
  • AUTOMATED ITERATIVE DRUG DISCOVERY AND SYNTHESIS
    Publication number: 20090209759
    Abstract: The present invention relates to methods and systems for de novo iterative synthesis, an automated iterative drug discovery method and system providing for rapid identification and synthesis of novel compounds.
    Type: Application
    Filed: June 18, 2007
    Publication date: August 20, 2009
    Applicant: Cresset Biomolecular Discovery, Ltd.
    Inventors: Brian Warrington, Jeremy Vinter, Mark Mackey
  • Microfluidic system
    Publication number: 20070116598
    Abstract: A system having a microfluidic channel structure in which fluids are able to interact to produce at least one product, and an automated closed-loop control mechanism to autonomously control a condition in, or of, the channel structure, the control mechanism having a sensor adapted to produce a sensor signal representative of a predetermined property of the at least one product which is dependent on the condition in, or of, the channel structure, means adapted to vary the condition in, or of, the channel structure, and a computer which is adapted to receive the sensor signal and to cause the means to vary the condition in, or of, the channel structure in dependence of the sensor signal is disclosed.
    Type: Application
    Filed: April 7, 2004
    Publication date: May 24, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: Ian Hughes, Brian Warrington, Yuk Wong